User profiles for Ángel J. García-Yagüe

Ángel Juan García Yagüe

Investigador contratado, Universidad Autónoma de Madrid
Verified email at iib.uam.es
Cited by 1440

The transcription factor Nrf2 is a therapeutic target against brain inflammation

NG Innamorato, AI Rojo, AJ García-Yagüe… - The Journal of …, 2008 - journals.aai.org
Because chronic neuroinflammation is a hallmark of neurodegenerative diseases and
compromises neuron viability, it is imperative to discover pharmacologic targets to modulate the …

Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes

M Pajares, N Jiménez-Moreno, ÁJ García-Yagüe… - Autophagy, 2016 - Taylor & Francis
Autophagy is a highly coordinated process that is controlled at several levels including
transcriptional regulation. Here, we identify the transcription factor NFE2L2/NRF2 (nuclear factor, …

Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease

I Lastres-Becker, AJ García-Yagüe… - Antioxidants & redox …, 2016 - liebertpub.com
Aims: This preclinical study was aimed at determining whether pharmacological targeting of
transcription factor NRF2, a master controller of many homeostatic genes, might provide a …

Cx3cr1‐deficiency exacerbates alpha‐synuclein‐A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease

S Castro‐Sánchez, ÁJ GarcíaYagüe, T López‐Royo… - Glia, 2018 - Wiley Online Library
Parkinson's disease (PD) is the second most common neurodegenerative disorder
characterized by the degeneration of dopaminergic neurons of the substantia nigra and the …

[HTML][HTML] Can activation of NRF2 be a strategy against COVID-19?

…, M Pajares, C Benito, J Jiménez-Villegas… - Trends in …, 2020 - cell.com
Acute respiratory distress syndrome (ARDS) caused by SARS-CoV-2 is largely the result of
a dysregulated host response, followed by damage to alveolar cells and lung fibrosis. …

[HTML][HTML] CX3CR1-deficient microglia shows impaired signalling of the transcription factor NRF2: Implications in tauopathies

S Castro-Sánchez, ÁJ García-Yagüe, S Kügler… - Redox biology, 2019 - Elsevier
TAU protein aggregation is the main characteristic of neurodegenerative diseases known
as tauopathies. Low-grade chronic inflammation is also another hallmark that indicates …

[HTML][HTML] Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy

AI Rojo, M Pajares, AJ García-Yagüe, I Buendia… - Redox biology, 2018 - Elsevier
Chronic neuroinflammation is a hallmark of the onset and progression of brain
proteinopathies such as Alzheimer disease (AD) and it is suspected to participate in the …

Role of MSK1 in the induction of NF-κB by the chemokine CX3CL1 in microglial cells

M Galán-Ganga, ÁJ García-Yagüe… - Cellular and molecular …, 2019 - Springer
Microglial cells are essential mediators of neuroinflammatory processes involved in several
pathologies. Moreover, the chemokine fractalkine (CX3CL1) is essential in the crosstalk …

[HTML][HTML] Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH

…, J Jiménez-Villegas, ÁJ García-Yagüe… - Redox Biology, 2024 - Elsevier
Non-alcoholic steatohepatitis (NASH) is a common chronic liver disease that compromises
liver function, for which there is not a specifically approved medicine. Recent research has …

Impaired signaling of NF-κB and NRF2 in CX3CR1-deficient microglia: Implications in tauopathies

S Castro-Sánchez, ÁJ García-Yagüe, S Kügler… - BioRxiv, 2018 - biorxiv.org
TAU protein aggregation is the main characteristic of neurodegenerative diseases known
as tauopathies. Low-grade chronic inflammation is also another hallmark that indicates …